Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer
Titel:
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer
Auteur:
Sarantopoulos, John Mita, Monica M. Birrer, Michael J. Cranmer, Lee D. Campos, Luis T. Zhang, Xiaoping Bristow, Penelope Kaito, Hidekuni Strout, Vincent Camacho, Luis H.